Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a series of open market sales transactions of the company's common stock on June 5, 2024. Afeyan disposed of a total of 15,000 shares at prices ranging from $145.91 to $154.86, resulting in a total market value of $2,268,803.77. Following these transactions, Afeyan directly holds 1,946,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. amount to 9,666,038 shares.